法诺巴比塔尔与年龄相关的影响,抑制发育中的大鼠产前与酒精暴露相关的发作
Tengfei Li1, George Luta1, Prosper N'Gouemo2
1Georgetown University Medical Center, Department of Biostatistics, Bioinformatics, and Biomathematics, Washington, DC 20057, United States.
Alcohol (Fayetteville, N.Y.)
|December 28, 2024
概括
产前酒精暴露会增加发育大鼠的发作风险. 费诺巴比塔尔有效地治疗老年 (P15) 但不是年轻 (P7) 的老鼠的发作,这表明需要对年轻的,暴露于酒精的新生儿进行新的治疗.
科学领域:
- 神经科学是一个神经科学.
- 发展生物学 发展生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 产前酒精暴露 (PAE) 与大脑发育中的发作易感性增加有关.
- 费诺巴比他 (PB) 在缓解PAE后N-甲基-d-阿斯巴达酸 (NMDA) 诱导的发作的疗效在很大程度上仍未被描述.
- 了解发作反应的发育差异对于有针对性的治疗干预至关重要.
研究的目的:
- 调查急性 (PB) 治疗对NMDA诱导的发作的影响,在患有产前酒精暴露 (PAE) 的老鼠中.
- 为了比较PB在抑制两种不同的发育阶段的发作的有效性:产后第7天 (P7) 和产后第15天 (P15).
- 探索使用PAE诱导发作的P7大鼠作为研究耐性的模型的潜力.
主要方法:
- 定时怀孕的斯普拉格-道利大鼠在妊娠第18天 (GD18) 接受了一次性酒精剂量.
- 在P7和P15的产后大鼠 (雄性和雌性) 接受了PB或载体.
- 使用NMDA实现了诱导,并记录了类型 (WRLB,FS,CS,GTCS,TS).
主要成果:
- 在产前暴露于酒精的老鼠表现出对NMDA诱导的全身性性-克隆性 (GTCS) 的敏感性增加,特别是在P7.7.
- 与P15大鼠相比,P7大鼠的Phenobarbital治疗在抑制PAE相关的发作方面效果较差.
- 较年轻的 (P7) 鼠对发作的延迟时间较短,并且在PB给药后更容易发生GTCS.
结论:
- 发育阶段显著影响了暴露于酒精的老鼠对法诺巴比塔尔的反应.
- 暴露于酒精的P7大鼠表现出一种形式的耐芬巴比塔尔的发作,突出了治疗挑战的关键窗口.
- P7PAE大鼠模型为研究早期发育中耐药性发作的机制提供了一个有价值的平台.
更多相关视频
15:27Construction of Vapor Chambers Used to Expose Mice to Alcohol During the Equivalent of all Three Trimesters of Human Development
Published on: July 13, 2014
14.7K
19:57The Use of Trace Eyeblink Classical Conditioning to Assess Hippocampal Dysfunction in a Rat Model of Fetal Alcohol Spectrum Disorders
Published on: August 5, 2017
8.3K
相关概念视频
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Inborn Errors of Metabolism
127
Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
127
